Hangzhou Tigermed Consulting (03347) spent 3.2604 million RMB to repurchase 67,000 A shares on January 22nd.

22/01/2025

GMT Eight

Hangzhou Tigermed Consulting (03347) announced that on January 22, 2025, it will spend 3.2604 million yuan to repurchase 67,000 shares of A-shares at a repurchase price of 48.54-48.97 yuan per share.

Weihai Huadong Automation (002248.SZ) announced a forecasted net profit of 7-10 million yuan for the 2024 fiscal year, turning losses into profits compared to the previous year.

Zhejiang Medicine (600216.SH) has announced a forecasted increase, expecting a net profit of 1.039-1.246 billion yuan in 2024, an increase of 141.83%-190.01% compared to the previous year.

Contact: contact@gmteight.com

Hangzhou Tigermed Consulting (03347) spent 3.2604 million RMB to repurchase 67,000 A shares on January 22nd.

RECOMMEND

US Stock Market Move | FuboTV (FUBO.US) rose more than 6% after reaching a merger agreement with the streaming services owned by Walt Disney Company (DIS.US) before.

US Stock Market Move | Income decreased in Q4 after adjustment, and Freeport-McMoRan Copper & Gold (FCX.US) fell more than 5%.

US Stock Market Move | Bank stocks rise across the board, Bank of America Corp (BAC.US) up 1.9%